Our results suggest that, in SKCM (Figure 11a), MESO (Figure 11b), HNSC (Figure 11c), and GBM (Figure 11d), patients with both low CAF infiltration and low GCKR expression tend to have a better prognosis. The gene discussed is GCKR; the disease is glioblastoma.